These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28577822)

  • 21. Lexical factors and cerebral regions influencing verbal fluency performance in MCI.
    Clark DG; Wadley VG; Kapur P; DeRamus TP; Singletary B; Nicholas AP; Blanton PD; Lokken K; Deshpande H; Marson D; Deutsch G
    Neuropsychologia; 2014 Feb; 54():98-111. PubMed ID: 24384308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehension of concrete and abstract words in semantic variant primary progressive aphasia and Alzheimer's disease: A behavioral and neuroimaging study.
    Joubert S; Vallet GT; Montembeault M; Boukadi M; Wilson MA; Laforce RJ; Rouleau I; Brambati SM
    Brain Lang; 2017 Jul; 170():93-102. PubMed ID: 28432988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Modal Data Analysis for Alzheimer's Disease Diagnosis: An Ensemble Model Using Imagery and Genetic Features.
    Ying Q; Xing X; Liu L; Lin AL; Jacobs N; Liang G
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():3586-3591. PubMed ID: 34892014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe.
    Nho K; Saykin AJ; ; Nelson PT
    J Alzheimers Dis; 2016; 52(1):373-83. PubMed ID: 27003218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of genetic difference between mild cognitive impairment and Alzheimer's disease through genome-wide association study].
    Bai Z; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):342-346. PubMed ID: 29896728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.
    Hayes JP; Logue MW; Sadeh N; Spielberg JM; Verfaellie M; Hayes SM; Reagan A; Salat DH; Wolf EJ; McGlinchey RE; Milberg WP; Stone A; Schichman SA; Miller MW
    Brain; 2017 Mar; 140(3):813-825. PubMed ID: 28077398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials.
    Hua X; Ching CRK; Mezher A; Gutman BA; Hibar DP; Bhatt P; Leow AD; Jack CR; Bernstein MA; Weiner MW; Thompson PM;
    Neurobiol Aging; 2016 Jan; 37():26-37. PubMed ID: 26545631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
    Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
    Reinvang I; Espeseth T; Westlye LT
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
    Teipel S; Grothe MJ;
    J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDiP technology for reverse engineering of sporadic Alzheimer's disease.
    Kondo T; Yada Y; Ikeuchi T; Inoue H
    J Hum Genet; 2023 Mar; 68(3):231-235. PubMed ID: 35680997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.
    Roussotte FF; Daianu M; Jahanshad N; Leonardo CD; Thompson PM
    Brain Imaging Behav; 2014 Jun; 8(2):217-233. PubMed ID: 24142306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Analysis of Association Between Calcium Signaling and Hippocampal Activation, Memory Performance in the Young and Old, and Risk for Sporadic Alzheimer Disease.
    Heck A; Fastenrath M; Coynel D; Auschra B; Bickel H; Freytag V; Gschwind L; Hartmann F; Jessen F; Kaduszkiewicz H; Maier W; Milnik A; Pentzek M; Riedel-Heller SG; Spalek K; Vogler C; Wagner M; Weyerer S; Wolfsgruber S; de Quervain DJ; Papassotiropoulos A
    JAMA Psychiatry; 2015 Oct; 72(10):1029-36. PubMed ID: 26332608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.
    Hao K; Di Narzo AF; Ho L; Luo W; Li S; Chen R; Li T; Dubner L; Pasinetti GM
    Mol Aspects Med; 2015; 43-44():66-76. PubMed ID: 26116273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
    Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
    Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased Glucose Metabolism in Medial Prefrontal Areas is Associated with Nutritional Status in Patients with Prodromal and Early Alzheimer's Disease.
    Sugimoto T; Nakamura A; Kato T; Iwata K; Saji N; Arahata Y; Hattori H; Bundo M; Ito K; Niida S; Sakurai T;
    J Alzheimers Dis; 2017; 60(1):225-233. PubMed ID: 28826182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimaging Genetics and Network Analysis in Alzheimer's Disease.
    Moon SW
    Curr Alzheimer Res; 2023; 20(8):526-538. PubMed ID: 37957920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.
    Cavedo E; Redolfi A; Angeloni F; Babiloni C; Lizio R; Chiapparini L; Bruzzone MG; Aquino D; Sabatini U; Alesiani M; Cherubini A; Salvatore E; Soricelli A; Vernieri F; Scrascia F; Sinforiani E; Chiarati P; Bastianello S; Montella P; Corbo D; Tedeschi G; Marino S; Baglieri A; De Salvo S; Carducci F; Quattrocchi CC; Cobelli M; Frisoni GB
    J Alzheimers Dis; 2014; 40(4):941-52. PubMed ID: 24577455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.